Corporate ManufacturerCached Profile
SUMITOMO PHARMA AMERICA
Manufacturer Corporate ID: 100001316929
Subsidiaries Logged: 1 entities
LIFETIME CORPORATE SPEND
$4,237,563
General Payments Aggregated (2021–2025)
Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.
Top Funded Physicians
Physicians receiving the highest promotional payments from this corporation.
1. Dr. WILLIAM WHITEMedical Doctor
$222,5302. Dr. JEFFREY FRANKELMedical Doctor
$151,2693. Dr. DAVID STASKINMedical Doctor
$112,0344. Dr. MATT ROSENBERGMedical Doctor
$87,9955. Dr. MICHAEL KENNELLYMedical Doctor
$83,710Top Promoted Products
Drugs or medical devices receiving the highest marketing backing.
1. GEMTESA$1,262,744 (29.8%)
2. ORGOVYX$1,093,704 (25.8%)
3. RETHYMIC$500,498 (11.8%)
4. MYFEMBREE$230,660 (5.4%)
5. APTIOM$60,312 (1.4%)
Active Subsidiary Entities
Corporate subsidiaries and brands associated with this manufacturer ID in Open Payments.
SUMITOMO PHARMA AMERICA, INC.
Corporate General Payouts Log
Federal registry records of promotional speaking, consulting, meals, and offsets.
Year:
2025
2025
2024
2023
2022
2021
Querying Open Payments Database
Fetching live CMS.gov records for SUMITOMO PHARMA AMERICA...